RE:RE:RE:Comparing DM with a couple other companiesDM, also has a Saliva based test that their waiting on from Health Canada. CBDT is already in the US with their Saliva based PCR test. It could be tough to break in with CBDT and many others already there or it could be easy as there may be lots to go around. That was not the point of my post.
The point is, based on current revenues and balance sheets DM is far ahead on that front, but is not getting the valuation it deserves. If those revenues should decline then I would expect the share price to decline, but lets get to a fair valuation first. I'm only looking at 10x valuation for DM, but THRM and CBDT are currently getting an average 26x valuation. The market doesn't always make sense, but that's why I look for these undervalued stocks that have a possible 10x increase. I believe DM fits that bill. Even if it only increases to half that we'll all be doing quite well with this stock.